Contact
Please use this form to send email to PR contact of this press release:
SFA THERAPEUTICS, INC. ANNOUNCES START OF PHASE 1b CLINICAL TRIAL IN THE TREATMENT OF MILD-to-MODERATE PLAQUE PSORIASIS
TO:
Ira Spector
SFA Therapeutics, Inc.
+1 267-584-1080